Nalaganje...
Finnish gelsolin amyloidosis causes significant disease burden but does not affect survival: FIN-GAR phase II study
BACKGROUND: Hereditary gelsolin (AGel) amyloidosis is an autosomal dominantly inherited systemic amyloidosis that manifests with the characteristic triad of progressive ophthalmological, neurological and dermatological signs and symptoms. The National Finnish Gelsolin Amyloidosis Registry (FIN-GAR)...
Shranjeno v:
| izdano v: | Orphanet J Rare Dis |
|---|---|
| Main Authors: | , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
BioMed Central
2020
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6969418/ https://ncbi.nlm.nih.gov/pubmed/31952544 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13023-020-1300-5 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|